HEPATOLOGY

HEPATOLOGY Journal

publication venue for

LONG-TERM MAINTENANCE OF RESPONSE AND IMPROVED LIVER HEALTH WITH MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC): 2-YEAR DATA FROM THE MARCH-ON STUDY 2024
LONG-TERM MAINTENANCE OF RESPONSE AND IMPROVED LIVER HEALTH WITH MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC): 2-YEAR DATA FROM THE MARCH-ON STUDY 2024
NON-INVASIVE FIBROSIS SCORING IN PATIENTS WITH WILSON DISEASE: A CROSS SECTIONAL ANALYSIS OF THE WILSON DISEASE REGISTRY STUDY 2023
EFFICACY AND SAFETY OF MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (MARCH-PFIC): A RANDOMIZED PLACEBO-CONTROLLED PHASE 3 STUDY 2023
IMPACT OF INITIAL POST-TRANSPLANT IMMUNOSUPPRESSION ON OUTCOMES IN THE 1st YEAR AFTER PEDIATRIC LIVER TRANSPLANT 2022
PATTERNS OF ALT AND AST, 24-HOUR URINE COPPER IN ADULT PATIENTS WITH TREATED WILSON DISEASE: RESULTS FROM AN INTERNATIONAL MULTI-SITE REGISTRY OVER THE COURSE OF 3 YEARS. 2022
REAL-WORLD SAFETY EXPERIENCE IN PATIENTS WITH ALAGILLE SYNDROME TREATED WITH MARALIXIBAT 2022
PATTERNS OF ALT AND AST IN ADULT PATIENTS WITH TREATED WILSON DISEASE: RESULTS FROM A MULTI-SITE REGISTRY 2021
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. 74:19-27. 2021
BILIARY STRICTURE PTC OR ERCP MANAGEMENT STRATEGIES IN CHILDREN POST LIVER TRANSPLANT: MULTICENTER ANALYSIS FROM THE SOCIETY OF PEDIATRIC LIVER TRANSPLANTATION REGISTRY 2020
CLINICAL UTILIZATION OF THE PELTOL ACROSS PEDIATRIC TRANSPLANT INSTITUTIONS: FINDINGS FROM THE SNEPT LEARNING NETWORK 2020
ELBASVIR/GRAZOPREVIR IN CHILDREN AGED 3 TO < 18 YEARS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE (GT) 1 OR 4 INFECTION: FINAL RESULTS FROM AN ITERATIVE PHARMACOKINETIC (PK) MODELING STUDY 2020
LONG TERM FOLLOW-UP OF SAFETY AND EFFICACY OF SOFOSBUVIR-BASED HCV DAAS IN PEDIATRIC PATIENTS 2020
QUALITY OF LIFE IN PEDIATRIC WILSON DISEASE: INITIAL ANALYSIS FROM A MULTI-SITE INTERNATIONAL REGISTRY 2020
SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTION IN ADOLESCENTS AND CHILDREN AGED 3 TO 17 YEARS OLD THROUGH 24 WEEKS POST-TREATMENT 2020
Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage. 72:1444-1454. 2020
INCIDENCE OF ACHIEVING WEIGHT LOSS GOALS IN USUAL CLINICAL PRACTICE: RESULTS FOR THE TARGET-NASH OBSERVATIONAL COHORT 2019
OUTCOMES OF LIVER TRANSPLANTATION AMONG OLDER RECIPIENTS WITH NASH IN A LARGE MULTICENTER US COHORT (REALT) 2019
PHARMACOKINETICS OF GLECAPREVIR/PIBRENTASVIR IN CHILDREN WITH CHRONIC HCV INFECTION: INTERIM ANALYSIS OF PART 2 OF THE DORA STUDY 2019
SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR IN PEDIATRIC PATIENTS 6 TO < 18 YEARS OLD WITH CHRONIC HEPATITIS C INFECTION 2019
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to < 12 Years With Hepatitis C Virus Genotype 2 or 3 Infection. 71:31-43. 2019
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. 68:2158-2166. 2018
Biliary Stricture Management and Outcomes Post-Liver Transplantation in Children: A Report from Studies of Pediatric Liver Transplantation (SPLIT) 2018
Entrustable Professional Activities (EPAs) for Transplant Hepatology 2017
Multicenter, Randomized Pilot Study of the Effect of Sorafenib Dosing Schedule on Tolerability and Drug Delivery 2017
Sofosbuvir and Ribavirin in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 2 or 3 Infection. 66:1102-1110. 2017
The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection. 66:371-378. 2017
Workforce in Hepatology: Update and a Critical Need for More Information. 65:336-340. 2017
A competency-based medical education pilot for training and certification in gastroenterology and transplant hepatology 2016
Prediagnostic Circulating Vitamin D Levels and Risk of Hepatocellular Carcinoma in European Populations: A Nested Case-Control Study. 60:1222-1230. 2014
Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer. 60:858-871. 2014
Evaluating Progression of Liver Disease From Repeat Liver Biopsies in Children With Chronic Hepatitis C: A Retrospective Study. 58:1580-1586. 2013
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial. 56:523-531. 2012
Histone Deacetylase Inhibition Suppresses the Transforming Growth Factor beta 1-Induced Epithelial-to-Mesenchymal Transition in Hepatocytes. 52:1033-1045. 2010
Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C trial. 47:836-843. 2008
Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+T cells by mouse liver. 39:1017-1027. 2004
Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. 39:403-411. 2004

category

GASTROENTEROLOGY & HEPATOLOGY Web of Science Category

International Standard Serial Number (ISSN)

0270-9139

Electronic International Standard Serial Number (EISSN)

1527-3350

journal abbreviation

HEPATOLOGY